CAN LOW REACTIVE-LEVEL LASER THERAPY BE USED IN THE TREATMENT OF NEUROGENIC FACIAL PAIN? A DOUBLE-BLIND, PLACEBO CONTROLLED INVESTIGATION OF PATIENTS WITH TRIGEMINAL NEURALGIA
スポンサーリンク
概要
- 論文の詳細を見る
Neurogenic facial pain has been one of the more difficult conditions to treat, but the introduction of laser therapy now permits a residual group of patients hitherto untreatable to achieve a life free from or with less pain. The present investigation was designed as a double-blind, placebo controlled study to determine whether low reactive-level laser therapy (LLLT) is effective for the treatment of trigeminal neuralgia. Two groups of patients (14 and 16) were treated with two probes. Neither the patients nor the dental surgeon were aware of which was the laser probe until the investigation had been completed. Each patient was treated weekly for five weeks. The results demonstrate that of 16 patients treated with the laser probe, 10 were free from pain after completing treatment and 2 had noticeably less pain, while in 4 there was little or no change. After a one year follow-up, 6 patients were still entirely free from pain. In the group treated with the placebo system, i.e. the non-laser probe, one was free from pain, 4 had less pain, and the remaining 9 patients had little or no recovery. After one year only one patient was still completely free from pain. The use of analgesics was recorded and the figures confirmed the fact that LLLT is effective in the treatment of trigeminal neuralgia. It is concluded that the present study clearly shows that LLLT treatment, given as described, is an effective method and an excellent supplement to conventional therapies used in the treatment of trigeminal neuralgia.
- 国際光治療学会の論文
国際光治療学会 | 論文
- IONTOPHORESIS-ENHANCED CUTANEOUS ABSORPTION OF 5-AMINOLEVULINIC ACID SHORTENS THE INCUBATION PERIOD IN PHOTODYNAMIC THERAPY
- THE RELATIVE EFFECTS OF He-Ne LASER AND MELOXICAM ON EXPERIMENTALLY INDUCED INFLAMMATION
- THE POSSIBILITY OF THE APPLICATION OF LOW REACTIVE LEVEL LASER THERAPY IN THE FIELD OF OPHTHALMOLOGY
- CRITICAL CONSIDERATIONS IN PROTOCOL DESIGN FOR A DOUBLE BLIND TRIAL ON PAIN ATTENUATION BY LASER THERAPY
- 820 NM GALLIUM ALUMINUM ARSENIDE LASER MODULATION OF PROSTAGLANDIN E2 PRODUCTION IN INTERLEUKIN I STIMULATED MYOBLASTS